| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/06/2004 | EP1272652B1 Herpes viruses for immune modulation |
| 10/06/2004 | EP1255548A4 Use of thiostrepton as an anti-mycobacterial agent |
| 10/06/2004 | EP1242107A4 Method for pr-39 peptide mediated selective inhibition of ikappabalpha degradation |
| 10/06/2004 | EP1206484B1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 10/06/2004 | EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use |
| 10/06/2004 | EP1144414B1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 10/06/2004 | EP1133284B1 A process for the preparation of crystalline particles |
| 10/06/2004 | EP1101112B1 Leptin-mediated gene-induction |
| 10/06/2004 | EP1100534A4 Equine system for non-surgical artificial insemination |
| 10/06/2004 | EP1071955B1 Improved immunodiagnostic assays using reducing agents |
| 10/06/2004 | EP1051433B1 Antimicrobial peptides |
| 10/06/2004 | EP1019096B1 Bioresorbable compositions for implantable prostheses |
| 10/06/2004 | EP0980252B1 Therapies for acute renal failure |
| 10/06/2004 | EP0941240B1 New picornaviruses, vaccines and diagnostic kits |
| 10/06/2004 | EP0938502B1 Selective acylation method |
| 10/06/2004 | EP0876498B1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv |
| 10/06/2004 | EP0869810B1 Cyclosporin-containing soft capsule preparations |
| 10/06/2004 | EP0840608B1 Orotate salts of 5-amino or substituted amino 1,2,3-triazoles for treatment of neoplasms |
| 10/06/2004 | EP0821551B1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 10/06/2004 | EP0706563B1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 10/06/2004 | EP0692024B1 An alpha-galactosidase enzyme |
| 10/06/2004 | EP0573611B9 Improved epitode displaying phage |
| 10/06/2004 | CN1535314A Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 10/06/2004 | CN1535313A Protein C or activated protein C-like molecules |
| 10/06/2004 | CN1535281A Peptides and related molecules that bind to TALL-1 |
| 10/06/2004 | CN1535264A Arginine derivatives |
| 10/06/2004 | CN1535168A Controlled release composition and method of producing the same |
| 10/06/2004 | CN1535163A Delivery system for nucleic acids |
| 10/06/2004 | CN1535160A Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 10/06/2004 | CN1535156A Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 10/06/2004 | CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl} |
| 10/06/2004 | CN1535151A Novel anti-infectives |
| 10/06/2004 | CN1535141A Sustained-release composition and process for producing the same |
| 10/06/2004 | CN1534094A Recombination protein for dissolving thrombus and its engineering bacteria |
| 10/06/2004 | CN1534093A Synthesis of batroxobin gene and purification preparation of its expresson product |
| 10/06/2004 | CN1534044A Recombination human interferon alpha 8 polypeptide coding cDNA sequence preparation method and application |
| 10/06/2004 | CN1534043A Ubiquition type molecule of human bone marrow substrate cell source and its coding sequence and use |
| 10/06/2004 | CN1534003A Animal and plant high effect ecological nutritive liquid and its preparation method |
| 10/06/2004 | CN1533808A Composition for treating coronavirus infection and SARS and method |
| 10/06/2004 | CN1533807A High dosage recombination human alpha interferon oral tablet and its manufacturing method |
| 10/06/2004 | CN1533806A Liver cell growing promotor injection and its preparation method and application |
| 10/06/2004 | CN1533762A Bionic skin and vagine nursing liquid |
| 10/06/2004 | CN1169966C Isolated, tyrosinase derived peptides and uses thereof |
| 10/06/2004 | CN1169959C Polypeptide variants with raised heparin-binding capacity |
| 10/06/2004 | CN1169958C Coding of human protein polynucleotide able to suppress growth of cancer cells |
| 10/06/2004 | CN1169957C Coding of human protein polynucleotide able to suppress growth of cancer cells |
| 10/06/2004 | CN1169956C Coding of human protein polynucleotide able to suppress growth of cancer cells |
| 10/06/2004 | CN1169951C Modified arginine deiminase |
| 10/06/2004 | CN1169835C Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof |
| 10/06/2004 | CN1169834C Process for separating megakaryocyte stimulating factor from human plasma and application |
| 10/06/2004 | CN1169833C Human Protein with cancer inhibiting function and its coding sequence |
| 10/06/2004 | CN1169831C Human protein with cancer call growth suppressing function and its coding sequence |
| 10/06/2004 | CN1169829C Non-T cell conjugating peptide and its use |
| 10/06/2004 | CN1169828C Disinfecting/permeability improved peptide allosteric in protein function region |
| 10/06/2004 | CN1169827C Method for improving stability of polypeptide in body and its application |
| 10/06/2004 | CN1169810C Peptide nucleic acid derivatives and preparing process, intermediate for preparing them and medicinal composition containing them |
| 10/06/2004 | CN1169578C Beaver thymosin injection and its prepn |
| 10/06/2004 | CN1169577C Recombinant human insulin compound, its prepn and medicine composition containing the compound |
| 10/06/2004 | CN1169576C Recombinant human granulocyte-macrophage colony stimulating factor gel |
| 10/06/2004 | CN1169575C Human tumor necrosis factor-alpha oral prepn. of marine polychlorella |
| 10/06/2004 | CN1169574C Ouabain conjugated peptide or protein and its application in treating hypertension |
| 10/06/2004 | CN1169573C Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides |
| 10/06/2004 | CN1169527C Methods of modulating serine-threnoine protein kinase function with 5-azaquinoxaline-based compounds |
| 10/05/2004 | US6800746 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/05/2004 | US6800745 For microbiocides |
| 10/05/2004 | US6800740 Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications |
| 10/05/2004 | US6800739 Isolation of glycoproteins from bovine milk |
| 10/05/2004 | US6800738 For cancer diagnosis and therapy; immunology; immunoglobulins |
| 10/05/2004 | US6800737 Amino acid sequences; anticaner agents, monitoring, diagnosis |
| 10/05/2004 | US6800735 Interferon-beta fusion proteins and uses |
| 10/05/2004 | US6800734 Membrane proteins, such as kinase, permease, mannosyltransferase and endoflagellin used to induce a protective immune response in animals; vaccines |
| 10/05/2004 | US6800732 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| 10/05/2004 | US6800731 For detecting myeloid cells expressing oncogene and therapeutic methods for treating cell-proliferative diseases |
| 10/05/2004 | US6800730 Such as tumor rejection antigens which bind human leukocyte antigen which provokes proliferation of cd4 cells; immunotherapy; anticarcinogenic agents; stimulation of cytotoxic t-cells |
| 10/05/2004 | US6800729 Human G-Protein chemokine receptor HDGNR10 (CCR5 receptor) |
| 10/05/2004 | US6800727 Peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof |
| 10/05/2004 | US6800616 Administering a therapeutic agent that is cytotoxic or cytostatic with respect to cd4+ t cells, but has reduced cytotoxic or cytostatic activity with respect to t lymphocyte stem cells |
| 10/05/2004 | US6800612 Have vasodilating activity and inhibit the aggregation of the platelets; releasing no |
| 10/05/2004 | US6800611 Metastin derivatives and their use |
| 10/05/2004 | US6800610 Osteoclast secreted chemokine and uses thereof |
| 10/05/2004 | US6800609 Isolated peptide of the horny layer and user thereof |
| 10/05/2004 | US6800608 Homogeneous assay of vancomycin using a stable particle-vancomycin conjugate, a novel rate enhancer, and a novel dose response modulator |
| 10/05/2004 | US6800607 Improved pharmacological activities, pharmacokinetics and physical properties; modified with 1-acyl-glycerol derivative |
| 10/05/2004 | US6800606 Compound having a molecular structure similar to that of human insulin, including disulphide bridges, and having insulin activity |
| 10/05/2004 | US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent |
| 10/05/2004 | US6800604 Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor |
| 10/05/2004 | US6800603 Promoting survival of neurons or nerve cells, stimulating cell differentiation, detecting and monitoring neuropathies; a biocompatible tubular casing having openings adapted to receive the ends of a severed nerve, promoting healing |
| 10/05/2004 | US6800483 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 10/05/2004 | US6800473 Cysteine proteases; drug discovery; for treating alzheimer's disease, pulmonary emphysema rheumatoid arthritis, muscular dystrophy, osteoporosis, neurodegenerative disease, cancer, metastasis |
| 10/05/2004 | US6800471 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/05/2004 | US6800470 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/05/2004 | US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 10/05/2004 | US6800460 Mammalian cytokine complexes |
| 10/05/2004 | US6800454 Nucleic acid molecule encoding chemokine-like factor 1 (CKLF1) |
| 10/05/2004 | US6800447 Methods for identifying compounds which bind the active CCR5 chemokine receptor |
| 10/05/2004 | US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/05/2004 | US6800443 Method of detecting a cancerous cell expressing an EGF motif polynucleotide |
| 10/05/2004 | US6800441 Heparanase specific molecular probes and their use in research and medical applications |
| 10/05/2004 | US6800434 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 10/05/2004 | US6800300 Method for treating autoimmune and alloimmune diseases |